Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD

American Journal of Kidney Diseases

Volumn 58, Issue 4, 2011, Pages 527-535

  Desrochers, Jean Franois ^a,b   Lemieux, Jean Philippe ^a,c   Morin Bélanger, Claudia ^a,c   Paradis, François Ste Marie ^a,b   Lord, Anne ^c   Bell, Robert ^b   Berbiche, Djamal ^c   Bárcena, Patricia Quintana ^a,c   Séguin, Noémie Charbonneau ^a,b   Desforges, Katherine ^a,c   Legris, Marie Ève ^a,b   Sauvé, Patricia ^a,c   Lalonde, Lyne ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c Centre de Sante et de Services Sociaux de Laval   (Canada)

Author keywords

Chronic kidney disease; community pharmacy; drug related problems; RAND appropriateness method; reliability; responsiveness; validity

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT TOOL; CRITERION RELATED VALIDITY; DRUG INDUCED DISEASE; GENERAL PRACTITIONER; INTERRATER RELIABILITY; NEPHROLOGIST; PHARMACIST; PHARMACOTHERAPY ASSESSMENT IN CHRONIC RENAL DISEASE; PREVALENCE; PSYCHOMETRY; RISK ASSESSMENT; TEST RETEST RELIABILITY; VALIDATION STUDY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CHRONIC DISEASE; COMMUNITY PHARMACY SERVICES; COUNSELING; DRUG TOXICITY; DRUG UTILIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; KIDNEY DISEASES; NEPHROLOGY; NONPRESCRIPTION DRUGS; OBSERVER VARIATION; PATIENT EDUCATION AS TOPIC; PHARMACY SERVICE, HOSPITAL; PILOT PROJECTS; PREVALENCE; PRIMARY HEALTH CARE; QUALITY IMPROVEMENT; REPRODUCIBILITY OF RESULTS;

EID: 80053053307     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.04.020     Document Type: Article

References (43)

1. R. London, A. Solis, G.A. Goldberg, S. Wade, and W.W. Chan Examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population J Manag Care Pharm 9 3 2003 248 255
2. J. Kappel, and P. Calissi Nephrology: 3 Safe drug prescribing for patients with renal insufficiency CMAJ 166 4 2002 473 477 (Pubitemid 34164099)
3. Q.L. Zhang, and D. Rothenbacher Prevalence of chronic kidney disease in population-based studies: systematic review BMC Public Health 8 2008 117
4. L.M. Strand, P.C. Morley, R.J. Cipolle, R. Ramsey, and G.D. Lamsam Drug-related problems: their structure and function DICP 24 11 1990 1093 1097
5. A. Spinewine, K.E. Schmader, and N. Barber Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370 9582 2007 173 184 (Pubitemid 47049724)
6. D.M. Fick, J.W. Cooper, W.E. Wade, J.L. Waller, J.R. Maclean, and M.H. Beers Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts Arch Intern Med 163 22 2003 2716 2724 (Pubitemid 37517412)
7. C.T. Naugler, C. Brymer, P. Stolee, and Z.A. Arcese Development and validation of an Improving Prescribing in the Elderly Tool Can J Clin Pharmacol 7 2 2000 103 107
8. P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, and D. O'Mahony STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment) Consensus validation Int J Clin Pharmacol Ther 46 2 2008 72 83 (Pubitemid 351233792)
9. P.J. McLeod, A.R. Huang, R.M. Tamblyn, and D.C. Gayton Defining inappropriate practices in prescribing for elderly people: a national consensus panel CMAJ 156 3 1997 385 391 (Pubitemid 27078035)
10. N.S. Wenger, and P.G. Shekelle Assessing Care of Vulnerable Elders: ACOVE project overview Ann Intern Med 135 8, pt 2 2001 642 646 (Pubitemid 33015477)
11. R.H. Brook, M.R. Chassin, A. Fink, D.H. Solomon, J. Kosecoff, and R.E. Park A method for the detailed assessment of the appropriateness of medical technologies Int J Technol Assess Health Care 2 1 1986 53 63
12. K. Fitch, S.J. Bernstein, and M.S. Aguilar The RAND/UCLA Appropriateness Method User's Manual 2001 Rand Corp Santa Monica, CA
13. I.P. Bridevaux, A.M. Silaghi, J.P. Vader, F. Froehlich, J.J. Gonvers, and B. Burnand Appropriateness of colorectal cancer screening: appraisal of evidence by experts Int J Qual Health Care 18 3 2006 177 182 (Pubitemid 43997302)
14. W.M. Bennett Drug Prescribing in Renal Failure 2007 American College of Physicians Philadelphia, PA
15. Natural Medicines Comprehensive Database http://naturaldatabase. therapeuticresearch.com Accessed August 23, 2010
16. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 2002 S1 S266 (suppl 1)
17. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease Am J Kidney Dis 42 4 2003 S1 S201 (suppl 3)
18. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Management of Dyslipidemias in Patients With Kidney Disease Am J Kidney Dis 41 4 2003 I IV (suppl 3), S1-91
19. National Kidney Foundation K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 5 2004 S1 S290 (suppl 1)
20. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease Am J Kidney Dis 49 2 2007 S12 S154 (suppl 2)
21. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 update of hemoglobin target Am J Kidney Dis 50 3 2007 471 530
22. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease Am J Kidney Dis 47 5 2006 S11 S145 (suppl 3)
23. National Kidney Foundation KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int Suppl 113 2009 S1 S130
24. J. Genest, R. McPherson, and J. Frohlich 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult2009 recommendations Can J Cardiol 25 10 2009 567 579
25. N.A. Khan, B. Hemmelgarn, and R.J. Herman The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2therapy Can J Cardiol 25 5 2009 287 298
26. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada Can J Diabetes 32 suppl 1 2008 S1 S201
27. G.R. Aronoff, W.M. Bennett, and J.S. Berns Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children 5th ed. 2007 American College of Physicians Philadelphia, PA
28. M. Normandeau Le programme ProFiL: un pont entre les pharmaciens communautaires et une clinique de prédialyse Québec Pharmacie 55 5 2008 24 26
29. L. Lalonde, M. Normandeau, and D. Lamarre Evaluation of a training and communication-network nephrology program for community pharmacists Pharm World Sci 30 6 2008 924 933
30. J.T. Hanlon, K.E. Schmader, and G.P. Samsa A method for assessing drug therapy appropriateness J Clin Epidemiol 45 10 1992 1045 1051
31. H.S. Hermanides, M.E. Hulscher, J.A. Schouten, J.M. Prins, and S.E. Geerlings Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care Clin Infect Dis 46 5 2008 703 711 (Pubitemid 351321554)
32. R. Kassam, L.G. Martin, and K.B. Farris Reliability of a modified medication appropriateness index in community pharmacies Ann Pharmacother 37 1 2003 40 46 (Pubitemid 36068596)
33. I. McDowell Measuring Health: A Guide to Rating Scales and Questionnaires 3rd ed. 2006 Oxford University Press New York, NY
34. W.G. Hopkins Calculating the reliability intraclass corelation coefficient and its confidence limits (Excel spreadsheet) http://www.sportsci. org/resource/stats/xICC.xls Accessed August 5, 2010
35. J. Etherington, G. Innes, and J. Christenson Development, implementation and reliability assessment of an emergency physician performance evaluation tool CJEM 2 4 2000 237 245
36. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1 1977 159 174 (Pubitemid 8054849)
37. H.J. Manley, C.A. Cannella, G.R. Bailie, and W.L. St Peter Medication-related problems in ambulatory hemodialysis patients: a pooled analysis Am J Kidney Dis 46 4 2005 669 680 (Pubitemid 41383945)
38. H.J. Manley, D.K. Drayer, and R.S. Muther Medication-related problem type and appearance rate in ambulatory hemodialysis patients BMC Nephrol 4 2003 10
39. M. Machado, J. Bajcar, G.C. Guzzo, and T.R. Einarson Sensitivity of patient outcomes to pharmacist interventions Part I: systematic review and meta-analysis in diabetes management Ann Pharmacother 41 10 2007 1569 1582 (Pubitemid 47479786)
40. M. Machado, J. Bajcar, G.C. Guzzo, and T.R. Einarson Sensitivity of patient outcomes to pharmacist interventions Part II: systematic review and meta-analysis in hypertension management Ann Pharmacother 41 11 2007 1770 1781 (Pubitemid 350044338)
41. M. Machado, N. Nassor, J.M. Bajcar, G.C. Guzzo, and T.R. Einarson Sensitivity of patient outcomes to pharmacist interventions Part III: systematic review and meta-analysis in hyperlipidemia management Ann Pharmacother 42 9 2008 1195 1207
42. Health Canada Notice of complianceChampix http://webprod3.hc-sc.gc.ca/ noc-ac/info.do?lang=eng&no=8984 Accessed August 5, 2010
43. Health Canada Notice of complianceRenagel http://webprod3.hc-sc.gc.ca/ noc-ac/info.do?lang=eng&no=9142 Accessed August 5, 2010